MF

Mohammed Faeez Mohammed Iliyas Pathan

Active Director Director DIN 11745514
DIN 11745514 First appointment May 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Mohammed Faeez Mohammed Iliyas Pathan

Data last updated:

Mohammed Faeez Mohammed Iliyas Pathan is a Director at Kanon Pharma Life Science Private Limited (since 2026).

DIN 11745514
Primary Designation Director
First Appointment 27 May 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 May 20262026Active

Board colleagues of Mohammed Faeez Mohammed Iliyas Pathan

Directorship timeline

Open interactive timeline →
Kanon Pharma Life Science Private Limited
Premium access

Shareholding and investment profile for Mohammed Faeez Mohammed Iliyas Pathan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mohammed Faeez Mohammed Iliyas Pathan

Mohammed Faeez Mohammed Iliyas Pathan currently holds 1 directorship: Kanon Pharma Life Science Private Limited (Director, since 27 May 2026).

Mohammed Faeez Mohammed Iliyas Pathan was first appointed on 27 May 2026 as Director at Kanon Pharma Life Science Private Limited.

The current boards of Mohammed Faeez Mohammed Iliyas Pathan's companies include Zeeshankhan Sabdalkhan Pathan (Kanon Pharma Life Science Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available